The Effects of Metformin on Age-Related Changes in the Liver Sinusoidal Endothelial Cell
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Age-related changes in the liver sinusoidal endothelium, particularly the reduction in fenestrations, contribute to insulin resistance in old age. Metformin impacts on the aging process and improves insulin resistance. Therefore, the effects of metformin on the liver sinusoidal endothelium were studied. Metformin increased fenestrations in liver sinusoidal endothelial cells isolated from both young and old mice. Mice administered metformin in the diet for 12 months had increased fenestrations and this was associated with lower insulin levels. The effect of metformin on fenestrations was blocked by inhibitors of AMP-activated protein kinase (AMPK), endothelial nitric oxide synthase, and myosin light chain kinase phosphorylation. Metformin led to increased transgelin expression and structural changes in the actin cytoskeleton but had no effect on lactate production. Metformin also generated fenestration-like structures in SK-Hep1 cells, a liver endothelial cell line, and this was associated with increased ATP, cGMP, and mitochondrial activity. In conclusion, metformin ameliorates age-related changes in the liver sinusoidal endothelial cell via AMPK and endothelial nitric oxide pathways, which might promote insulin sensitivity in the liver, particularly in old age.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The mechanisms of action of metformin
Rena, G., Hardie, D. G., & Pearson, E. R. (2017) · Diabetologia · doi:10.1007/s00125-017-4342-z · Cited by 2,287
The Kinase LKB1 Mediates Glucose Homeostasis in Liver and Therapeutic Effects of Metformin
Shaw, R. J., Lamia, K. A., Vasquez, D., Koo, S.-H., Bardeesy, N., DePinho, R. A., Montminy, M., & Cantley, L. C. (2005) · Science · doi:10.1126/science.1120781 · Cited by 1,950
Metformin improves healthspan and lifespan in mice
Martin-Montalvo, A., Mercken, E. M., Mitchell, S. J., Palacios, H. H., Mote, P. L., Scheibye-Knudsen, M., Gomes, A. P., Ward, T. M., Minor, R. K., Blouin, M.-J., et al. (2013) · Nature Communications · doi:10.1038/ncomms3192 · Cited by 1,445
Metformin as a tool to target aging
Barzilai, N., Crandall, J. P., Kritchevsky, S. B., & Espeland, M. A. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.05.011 · Cited by 1,096
Liver sinusoidal endothelial cells in hepatic fibrosis
DeLeve, L. D. (2015) · Hepatology · doi:10.1002/hep.27376 · Cited by 482 · cited 1×
“These pathways are similar to those we and others have previously reported for several other agents that increase fenestrations in LSECs (19,30).”
ResultXie, G., Wang, X., Wang, L., Wang, L., Atkinson, R. D., Kanel, G. C., Gaarde, W. A., & DeLeve, L. D. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.12.017 · Cited by 410
Howell, J. J., Hellberg, K., Turner, M., Talbott, G., Kolar, M. J., Ross, D. S., Hoxhaj, G., Saghatelian, A., Shaw, R. J., & Manning, B. D. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2016.12.009 · Cited by 408 · cited 1×
“The primary target organ of metformin is the liver (5,6) where metformin downregulates protein synthesis (7), lipogenesis (8,9), and gluconeogenesis (10), and upregulates insulin signaling (8,11).”
BackgroundDeLeve, L. D., Wang, X., & Guo, Y. (2008) · Hepatology · doi:10.1002/hep.22351 · Cited by 408 · cited 1×
“The restoration of a healthy LSEC phenotype (fenestrated and nitric oxide releasing) has been shown to prevent fibrosis progression and regression of fibrosis (38,39).”
BackgroundDetaille, D., Guigas, B., Chauvin, C., Batandier, C., Fontaine, E., Wiernsperger, N., & Leverve, X. (2005) · Diabetes · doi:10.2337/diabetes.54.7.2179 · Cited by 263
Metformin: A Hopeful Promise in Aging Research
Novelle, M. G., Ali, A., Diéguez, C., Bernier, M., & de Cabo, R. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025932 · Cited by 178
Cited by
Hallmarks of Aging in the Liver
Hunt, N. J., Kang, S. W. (., Lockwood, G. P., Le Couteur, D. G., & Cogger, V. C. (2019) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2019.07.021 · Cited by 306
Self-citationCell senescence in liver diseases: pathological mechanism and theranostic opportunity
Sanfeliu-Redondo, D., Gibert-Ramos, A., & Gracia-Sancho, J. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-024-00913-4 · Cited by 117
“In a preclinical study in young and aged mice, metformin ameliorated the typical changes in LSECs caused by age, including increased cell fenestrations, through upregulation in AMPK1 signalling, endothelial nitric oxide synthase (eNOS) and myosin light chain kinase phosphorylation 154 .”
Role of Oxidative Stress in Liver Disorders
Conde de la Rosa, L., Goicoechea, L., Torres, S., Garcia-Ruiz, C., & Fernandez-Checa, J. C. (2022) · Livers · doi:10.3390/livers2040023 · Cited by 107
Autophagy and senescence: the molecular mechanisms and implications in liver diseases
Li, Q., Lin, Y., Liang, G., Xiao, N., Zhang, H., Yang, X., Yang, J., & Liu, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242316880 · Cited by 43
“Metformin can ameliorate the aging process of ISEC by increasing fenestration through activating AMPK and endothelial nitric oxide pathways [200].”
BackgroundSinusoidal communication in chronic liver disease
Gibert-Ramos, A., Andrés-Rozas, M., Pastó, R., Alfaro-Retamero, P., Guixé-Muntet, S., & Gracia-Sancho, J. (2025) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2024.0734 · Cited by 20
“This novel approach is promising, as metformin treatment in cirrhotic rats has shown a decrease in fibrosis, portal pressure and hepatic vascular resistance(164), while in aged mice has shown a restoration in the number of fenestrations in LSECs(165), key in sinusoidal communication.”
Background
Metadata
- Authors
- Hunt, N. J., Lockwood, G. P., Kang, S. W. (., Pulpitel, T., Clark, X., Mao, H., McCourt, P. A. G., Cooney, G. J., Wali, J. A., Le Couteur, F. H., Le Couteur, D. G., & Cogger, V. C.
- Venue
- The Journals of Gerontology: Series A
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-06-14
- Volume
- 75
- Issue
- 2
- Pages
- 278-285
- ISSN
- 1079-5006 (ISSN-L)
- 1758-535X
- OpenAlex
- W2953256887
- Cited by
- 44
- References
- 12
- FWCI
- 1.79
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Effects of Metformin on Age-Related Changes in the Liver Sinusoidal Endothelial Cell. https://app.cochat.ai/papers/10.1093/gerona/glz153
- The paper
- Hunt, N. J., Lockwood, G. P., Kang, S. W. (., Pulpitel, T., Clark, X., Mao, H., McCourt, P. A. G., Cooney, G. J., Wali, J. A., Le Couteur, F. H., Le Couteur, D. G., & Cogger, V. C. (2019). The Effects of Metformin on Age-Related Changes in the Liver Sinusoidal Endothelial Cell. The Journals of Gerontology: Series A. https://doi.org/10.1093/gerona/glz153
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.